HIGHLIGHTS
- who: Report and colleagues from the Laboratory finding have published the paper: Review began 12/17/2022 Review ended 12/24/2022 Published 12/31/2022 u00a9 Copyright, in the Journal: (JOURNAL) of December/31,/2022
- what: The authors report a case of an elderly woman treated with empagliflozin who presented with EDKA as a postop complication.
SUMMARY
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are oral antidiabetic class drugs with rising popularity due to its high safety profile and broad cardio- and nephroprotective effects. Euglycemic diabetic ketoacidosis (EDKA) is a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.